iShares Biotechnology ETF

IBB

Market cap $6.14B

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on February 5, 2001.

Destiny Wealth Partners reported in an SEC filing on Monday that it sold 59,354 shares of the iShares Biotechnology ETF (IBB) in the third quarter—an estimated $8.1 million transaction based on average pricing for the quarter.

While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck and Pfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their portfolios of drugs.

The Fast Money traders discuss why health care stocks look attractive on valuations, how underweight positioning could drive sustainability, why recent White House policy moves may be a “gift” to pharma companies, and more.

President Donald Trump delivered the pharmaceutical industry another blow this week, threatening 100% tariffs on some companies.

The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on the surface. Year-to-date, the iShares Nasdaq Biotechnology ETF NASDAQ: IBB, which tracks the NASDAQ Biotechnology Index, is up just over 8%.

This is a good time to step back and gain some perspective on the key ETFs I follow as the market anticipates several economic happenings, such as: I start with the Transportation Sector ETF (NYSEARCA: IYT) looking at the weekly chart.

Biotech is back – and it's playing for keeps. President Donald Trump's second-term policies have unleashed a staggering ~$350 billion surge in U.S.-based pharmaceutical and biotech investments, from domestic manufacturing to cutting-edge R&D.

Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.

Even with Monday's correction, small caps continue to see rotation.  The Russell 2000 ETF (NYSEARCA: IWM) had a topping pattern last week.